"Maternité Angers : le respect de votre projet de naissance. Maternité de référence, accoucher autrement. Le pôle de gynécologie-obstétrique du C.H.U. d'Angers vous accueille tant pour votre suivi de grossesse et votre accouchement, que pour votre prise en charge gynécologique. Au sein de la maternité du C.H.U. Angers, l'équipe vous accompagnera dans le respect de votre projet de naissance avec toute la sécurité d'une maternité de niveau III."

During the past decade, CHU Angers conducted 570 clinical trials. In the 10-year time frame, 570 clinical trials started and 58 clinical trials were completed, i.e. on average, 10.2% percent of trials that started reached the finish line to date. In the past 5 years, 292 clinical trials started and 47 clinical trials were completed. i.e. 16.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Angers" #1 sponsor was "University Hospital, Angers" with 87 trials, followed by "Nantes University Hospital" with 57 trials sponsored, "University Hospital, Brest" with 37 trials sponsored, "Rennes University Hospital" with 30 trials sponsored and "Groupe Francophone des Myelodysplasies" with 30 trials sponsored. Other sponsors include 558 different institutions and companies that sponsored additional 216 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Angers" #1 collaborator was "Ministry of Health, France" with 21 trials as a collaborator, "University Hospital, Angers" with 9 trials as a collaborator, "Roche Pharma AG" with 8 trials as a collaborator, "National Cancer Institute, France" with 7 trials as a collaborator and "Novartis" with 7 trials as a collaborator. Other collaborators include 501 different institutions and companies that were collaborators in the rest 358 trials.

According to Clinical.Site data, the most researched conditions in "CHU Angers" are "Myelodysplastic Syndromes" (22 trials), "Acute Myeloid Leukemia" (12 trials), "Carcinoma, Non-Small-Cell Lung" (10 trials), "Multiple Myeloma" (10 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "CHU Angers" in a lesser frequency.

Most popular intervention types in "CHU Angers" are "Drug" (372 trials), "Other" (163 trials), "Device" (100 trials), "Procedure" (73 trials) and "Biological" (32 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (62 trials), "Lenalidomide" (11 trials), "Carboplatin" (10 trials), "Gemcitabine" (10 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "CHU Angers" are 754 trials for "All" genders, 33 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "CHU Angers". 14 are not yet recruiting, 206 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 368 completed trials in CHU Angers, 2 suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Angers, 28 "Phase 1" clinical trials were conducted, 168 "Phase 2" clinical trials and 199 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 195 trials that are defined as “Not Applicable".

CHU Angers has several departments that took part in Clinical trials: "CHU Angers - DEPARTEMENT D'ANESTHESIE REANIMATION" - 5 trials, "Service de Pneumologie, CHU Angers" - 4 trials, "CHU Angers Service de Dermatologie" - 3 trials, "CHU Angers-Service d'Hepato-Gastroenterologie" - 2 trials, "Virologie" - 2 trials, "Service de Cardiologie - CHU d'Angers" - 2 trials, "Néphrologie" - 2 trials, "CHU Angers, Batiement Larrey 2, Neurologie" - 2 trials, "CHU-ANGERS -Médecine Interne" - 2 trials